Kadcyla 160mg Injection

Kadcyla 160mg Injection contains the active ingredient ado-trastuzumab emtansine. It is a prescription medication used to treat HER2-positive breast cancer that has spread to other parts of the body or has not responded to other treatments. It is a combination of two drugs: trastuzumab, which is an antibody that targets HER2 receptors, and emtansine, which is a chemotherapy drug that kills cancer cells. It is indicated to treat breast cancer in the early stages as well as advanced stages, where patients develop recurrence within six months of chemotherapy treatment. This medication acts against tumours that produce more than the normal amount of a certain protein known as HER2 protein. Patients with residual breast cancer after chemotherapy treatment and HER2-targeted therapy have a poorer prognosis than those with no residual cancer. Report to your physician immediately if you experience side effects such as allergic reactions or unusual bleeding. This medication does not show any adverse effects on the kidney. In rare cases, an infusion reaction is seen. Like all other medications, it shows mild side effects including nausea, vomiting, diarrhoea, and hair loss.

Kadcyla Injection uses are as follows: Advanced and metastatic breast cancer Metastatic gastric cancer

Ado-Trastuzumab emtansine works by combining the targeting ability of trastuzumab, which binds to HER2-positive cancer cells, with the cell-killing effects of emtansine, a chemotherapy drug. Once this medication binds to the HER2-positive cancer cells, it releases emtansine, which then enters the cancer cells and destroys them. This process helps to slow down or stop the growth of cancer, reducing the size of tumours and potentially extending the patient's life.

Kadcyla 160mg Injection is administered by a healthcare professional in a hospital or clinic setting. The dose and frequency depend on several factors, such as the individual's age, weight, overall health, and the type and stage of the cancer being treated. If a dose is missed, it should be taken as soon as possible unless it's almost time for the next scheduled dose, in which case the missed dose should be skipped, and the regular dosing schedule resumed. Do not double the dose to make up for missed doses.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Kadcyla 160mg Injection can cause side effects as follows: Serious: Infusion reactions, including fever, chills, rash, or difficulty breathing Lung problems, including shortness of breath, cough, or fever Heart problems, including heart failure or abnormal heart rhythms Severe bleeding or bruising Nerve damage, including numbness, tingling, or weakness Severe allergic reactions Common: Fatigue Nausea Constipation Muscle or joint pain Headache Fever Low platelet count High liver enzyme levels Low red blood cell count Loss of appetite Rash or itching

If you are receiving Kadcyla 160mg Injection, it's important to be proactive in managing your treatment and monitoring your symptoms. Keep communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Use effective birth control during the treatment and at least 7 weeks after the last dose. Immediately contact your healthcare provider in case of any worsening of symptoms or infusion reactions. Take steps to care for yourself physically and emotionally during treatment, and seek support from loved ones and professionals as needed. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. Being informed and engaged in your treatment can help ensure the best possible outcomes and manage potential risks or complications.